Estrella Immunopharma, Inc. (ESLA)
NASDAQ: ESLA · Real-Time Price · USD
0.8549
+0.0149 (1.77%)
Aug 1, 2025, 4:00 PM - Market closed

Accolade Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '25 Dec '24 Jun '24 Jun '23 Jun '22 Jun '21
31433819--
Market Cap Growth
-26.15%13.67%101.23%---
Enterprise Value
31423321--
Last Close Price
0.851.201.0510.8410.00-
PB Ratio
-302.068.94-2.81--
P/TBV Ratio
-302.068.94---
Debt / Equity Ratio
0.000.030.000.00--
Quick Ratio
0.100.3123.050.254.32-
Current Ratio
0.220.5524.650.285.20-
Return on Assets (ROA)
---122.12%-174.75%--
Earnings Yield
-33.92%-20.39%-19.14%-58.56%--
Buyback Yield / Dilution
-92.20%-34.73%-8764.81%---
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q